Company profile: Elucid
1.1 - Company Overview
Company description
- Provider of AI-powered CT angiography image analysis for cardiovascular precision medicine. Offers PlaqueIQ and ElucidVivo software to quantify arterial plaque extent, stability, and composition; restore vessel structure and plaque morphology for 3D visibility (validated with histopathology); integrate with CTA scanners, EMR, and PACS; combine FFRCT with plaque analysis; and support clinical research.
Products and services
- PlaqueIQ Technology: Non-invasive software leveraging CT angiography (CTA) and computer algorithms to quantify arterial plaque extent and stability, enabling cardiovascular risk stratification and personalized treatment planning
- PlaqueIQ Translate CTA into Scientific Images: Histopathology-validated software that restores vessel structure and plaque morphology from CTA, delivering complete 3D plaque visibility and analysis to inform cardiovascular disease assessment
- ElucidVivo FFRCT + PlaqueIQ: FFR-integrated software that combines plaque analysis with fractional flow reserve (FFR) to measure stress-induced ischemia and characterize plaque risk for clinical decision-making
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Elucid
Kobus
HQ: France
Website
- Description: Provider of a digital assistant that facilitates the daily life of physiotherapists.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kobus company profile →
Midi Health
HQ: United States
Website
- Description: Provider of virtual care for women, offering clinician consultations, personalized prescriptions shipped to patients, follow-up visits to adjust treatment, referrals to local facilities for bloodwork or imaging, specialty visits, and treatment for menopause symptoms, depression, gynecological cancer, and period problems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Midi Health company profile →
Kaiku Health
HQ: Finland
Website
- Description: Provider of an intelligent digital health platform for monitoring patient-reported outcomes across therapy areas including cancer care, fertility treatments, and preventive health care. Offers a platform for cancer clinics with intelligent symptom tracking, symptom management modules for immune-related adverse events in immunotherapies (Immune Checkpoint Inhibitor and CAR T), and an online GIST risk calculator to guide post-surgery treatment evaluation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kaiku Health company profile →
HealthcareSource
HQ: United States
Website
- Description: Provider of a comprehensive healthcare talent management suite used by more than 3,300 healthcare organizations and staffing agencies to recruit, retain, and develop talent to ensure quality patient care. Offerings include software, services, content, and analytics such as symplr Recruiting and symplr Talent Analytics for data-driven HR decisions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HealthcareSource company profile →
MAK-SYSTEM
HQ: France
Website
- Description: Provider of web-based software for healthcare organizations in France and internationally, including blood management systems for blood, plasma, tissue, and biologics; ePROGESA for blood banking and transfusion; eTRACE LINE safeguarding the transfusion therapy cycle; transfusion management for hospitals and labs; cell and gene therapy and donor relationship platforms; MAK.care and cloud managed services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MAK-SYSTEM company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Elucid
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Elucid
2.2 - Growth funds investing in similar companies to Elucid
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Elucid
4.2 - Public trading comparable groups for Elucid
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →